文献速递乳腺癌支持与姑息治疗

电子健康干预对乳腺癌患者的效果:系统评价与Meta分析

Electronic Health Interventions for Patients With Breast Cancer: Systematic Review and Meta-Analyses.
PubMed 文献 · J Clin Oncol · 2022-05-02

该系统评价与Meta分析纳入32项随机对照试验共4790例乳腺癌患者,评估以患者为导向的电子健康干预对患者报告结局的效果。结果显示电子健康干预对生活质量(SMD 0.20)、自我效能(SMD 0.45)、痛苦(SMD -0.41)和疲乏(SMD -0.37)均有显著效果,可接受性高但参与度随时间下降。

要点

  • 电子健康干预可改善乳腺癌患者生活质量、自我效能、痛苦和疲乏。
  • 可接受性高,满意度71%-100%,有用性71%-95%,易用性73%-92%。
  • 参与度随时间下降,以疾病信息和互动支持最吸引参与。

核心结论

  • 电子健康干预可能为改善乳腺癌患者的生活质量、痛苦、自我效能和疲乏提供一种可接受且有效的策略。

研究设计与样本

  • 遵循PRISMA指南的系统评价与Meta分析(随机效应模型),检索9个数据库,纳入32项独特研究共4790例患者。
  • 纳入标准为针对成人乳腺癌患者积极治疗期间或之后、以患者为导向的电子健康干预,测量生活质量、自我效能及心理或身体健康结局的随机对照试验。
  • 所有纳入研究均为健康自我管理干预,多数为多组分(视频、论坛和电子提醒系统)网站。
  • 数据由6名观察者独立提取。

主要发现

  • 电子健康干预对生活质量有显著效果(SMD 0.20,95%CI 0.03至0.36)。
  • 电子健康干预对自我效能有显著效果(SMD 0.45,95%CI 0.24至0.65)。
  • 电子健康干预对痛苦有显著效果(SMD -0.41,95%CI -0.63至-0.20)。
  • 电子健康干预对疲乏有显著效果(SMD -0.37,95%CI -0.61至-0.13)。
  • 25项研究(78.1%)测量了患者报告体验指标;可接受性(n=9)高,满意度范围71%-100%,有用性范围71%-95%,易用性范围73%-92%;参与度(n=25)随时间下降,以疾病聚焦信息和互动支持最吸引参与。

临床怎么用

  • 原文结论指出电子健康干预可能为改善乳腺癌患者生活质量、痛苦、自我效能和疲乏提供可接受且有效的策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Ongoing supportive care using electronic health (eHealth) interventions has the potential to provide remote support and improve health outcomes for patients with breast cancer. This study aimed to evaluate the effectiveness of eHealth interventions on patient-reported outcomes (quality of life [QOL], self-efficacy, and mental or physical health) for patients during and after breast cancer treatment and patient-reported experience measures (acceptability and engagement). METHODS: Systematic review with meta-analyses (random-effects model) of randomized controlled trials was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Nine databases were searched using a prespecified search strategy. Patient-directed eHealth interventions for adult patients during or after active breast cancer treatment measuring QOL, self-efficacy, and mental (depressive, anxiety, and distress symptoms) or physical (physical activity, nutrition, and fatigue) health outcomes were included. Data from eligible full-text articles were independently extracted by six observers. RESULTS: Thirty-two unique studies (4,790 patients) were included. All were health self-management interventions, and most were multicomponent (videos, forums, and electronic reminder systems) websites. Meta-analyses revealed a significant effect of eHealth interventions on QOL (standardized mean difference [SMD], 0.20 [95% CI, 0.03 to 0.36]), self-efficacy (SMD, 0.45 [95% CI, 0.24 to 0.65]), distress (SMD, -0.41 [95% CI,-0.63 to -0.20]), and fatigue (SMD, -0.37 [95% CI, -0.61 to -0.13]). Twenty-five studies (78.1%) measured patient-reported experience measures. Acceptability (n = 9) was high, with high ratings for satisfaction (range, 71%-100%), usefulness (range, 71%-95%), and ease-of-use (range, 73%-92%). Engagement (n = 25) decreased over time, but disease-focused information and interactive support were most engaging. CONCLUSION: eHealth interventions may provide an acceptable and effective strategy for improving QOL, distress, self-efficacy, and fatigue among patients with breast cancer.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Singleton AC, Raeside R, Hyun KK, et al. Electronic Health Interventions for Patients With Breast Cancer: Systematic Review and Meta-Analyses. J Clin Oncol. 2022. PMID: 35500200. doi:10.1200/JCO.21.01171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。